Table 2 Viral suppression at enrolment compared to 48 weeks, among those with both valid results
VL at 48 weeks (copies/mL) | ||||
|---|---|---|---|---|
< 1000 | ≥ 1000 | Total | ||
VL at enrolment (copies/mL) | < 1000 | 150 (47.9%) | 27 (8.6%) | 177 (56.5%) |
≥ 1000 | 49 (15.7%) | 87 (27.8%) | 136 (43.5%) | |
Total | 199 (63.6%) | 114 (36.4%) | 313 (100%) | |